(Bloomberg) — MannKind Corp., the biotechnology company run by billionaire inventor Alfred Mann, failed to win approval from U.S. regulators to market its inhaled insulin drug, Afrezza, for people with diabetes.The Food and Drug Administration questioned for more information about the medication, Valencia, California-based MannKind said today in a statement.
Posts Tagged ‘Biotechnology Company’
MannKind’s Insulin Afrezza Fails to Win Approval
March 15th, 2010 
Before You Invest 
Posted in Finance Fraud 
Tags: Alfred Mann, Biotechnology Company, Diabetic Patients, Drug Application, Eli Lilly, Food And Drug Administration, Hormone Insulin, Inhaled Insulin, Inhaler, Insulin Product, Launch, Mannkind Corp, Matthew Pfeffer, Nasdaq, New Application, New York Time, Percentage Decline, Safety Concerns, Safety Data, Valencia California 
Comments Off
